ডি49- নিঅ'প্লাজম
A study to find which drug (metoclopramide, thalidomide, prochlorperazine, or lorazepam) is best to treat vomiting due to chemotherapy in patients with cancer.
হস্পিতালৰ লগত যোগাযোগ কৰক
ৰেজিষ্ট্ৰীয়ে এই হস্পিতালটোক ট্ৰায়েলৰ মূল যোগাযোগ হিচাপে নাম দিছে। তেওঁলোকক সোধক কোনবোৰ হস্পিতালত ৰোগী লৈ আছে।
ৰেজিষ্ট্ৰীৰ সাৰাংশ (কাৰিকৰী)
An open-label phase III randomized controlled trial comparing metoclopramide, thalidomide, prochlorperazine, and lorazepam for treating breakthrough chemotherapy-induced nausea and vomiting in patients receiving olanzapine as part of antiemetic prophylaxis for highly emetogenic chemotherapy. - Nil
Sponsor: Cancer Institute WIA
CTRI-ত CTRI/2024/08/072429, ভাৰতৰ trial registry
Source: Clinical Trials Registry – India (CTRI), WHO ICTRP-ৰ জৰিয়তে, 12 Oct 2026-ৰ data
Last updated on the registry 22 Jun 2026 · read by us 5 Nov 2026